These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11938479)

  • 21. Unlicensed and off label drug use in neonates.
    Conroy S; McIntyre J; Choonara I
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F142-4; discussion F144-5. PubMed ID: 10325794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unlicensed and off-label drug use in a neonatal unit in France.
    Nguyen KA; Claris O; Kassai B
    Acta Paediatr; 2011 Apr; 100(4):615-7. PubMed ID: 21410525
    [No Abstract]   [Full Text] [Related]  

  • 23. Off-label and unlicensed medication use and associated adverse drug events in a pediatric emergency department.
    Phan H; Leder M; Fishley M; Moeller M; Nahata M
    Pediatr Emerg Care; 2010 Jun; 26(6):424-30. PubMed ID: 20502385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital.
    't Jong GW; Vulto AG; de Hoog M; Schimmel KJ; Tibboel D; van den Anker JN
    Pediatrics; 2001 Nov; 108(5):1089-93. PubMed ID: 11694685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.
    Dick A; Keady S; Mohamed F; Brayley S; Thomson M; Lloyd BW; Heuschkel R; Afzal NA
    Aliment Pharmacol Ther; 2003 Feb; 17(4):571-5. PubMed ID: 12622766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of off-label drugs in neonatal intensive care].
    Sucasas Alonso A; Avila-Alvarez A; Combarro Eiriz M; Martínez Roca C; Yáñez Gómez P; Codias López A; Fernández Trisac JL; Pértega Díaz S
    An Pediatr (Engl Ed); 2019 Oct; 91(4):237-243. PubMed ID: 30772271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription of off-label and unlicensed drugs for preterm infants in a neonatal intensive care unit.
    Vieira VC; Costa RS; Lima RCG; Queiroz DB; Medeiros DS
    Rev Bras Ter Intensiva; 2021; 33(2):266-275. PubMed ID: 34231807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit.
    Gidey MT; Gebretsadkan YG; Tsadik AG; Welie AG; Assefa BT
    Ital J Pediatr; 2020 Apr; 46(1):41. PubMed ID: 32245504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I; Conroy S
    Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.
    Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC
    Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Food and Drug Administration approval for medications used in the pediatric intensive care unit: a continuing conundrum.
    Yang CP; Veltri MA; Anton B; Yaster M; Berkowitz ID
    Pediatr Crit Care Med; 2011 Sep; 12(5):e195-9. PubMed ID: 21057369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit.
    Arocas Casañ V; Cabezuelo Escribano B; Garrido-Corro B; De la Cruz Murie P; Blázquez Álvarez MJ; De la Rubia Nieto MªA
    Farm Hosp; 2017 May; 41(3):371-381. PubMed ID: 28478751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Off licence and off label prescribing in children: litigation fears for physicians.
    Hill P
    Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i17-8. PubMed ID: 15665151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
    Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
    Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit.
    Santos LGD; Santos JGD; Iser BM; Kock KS; Bó KD
    Rev Paul Pediatr; 2023; 42():e2023023. PubMed ID: 37729244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of dosage prescribing medication errors associated with manual prescriptions for very preterm infants.
    Horri J; Cransac A; Quantin C; Abrahamowicz M; Ferdynus C; Sgro C; Robillard PY; Iacobelli S; Gouyon JB
    J Clin Pharm Ther; 2014 Dec; 39(6):637-41. PubMed ID: 25060391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran.
    Kouti L; Aletayeb M; Aletayeb SMH; Hardani AK; Eslami K
    BMC Pediatr; 2019 Jan; 19(1):3. PubMed ID: 30609923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of off-label and unlicensed medicines in neonatal intensive care.
    Costa HTML; Costa TX; Martins RR; Oliveira AG
    PLoS One; 2018; 13(9):e0204427. PubMed ID: 30252920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.